INO Health & Biotech Stock Guide
Preview Issue #11 - February 28, 2017
BIOTECH, HEALTH & PHARMA NEWS
Johnson & Johnson and McKesson make a big splash in merger and acquisition activity, courts block Humana/Aetna merger and Allergan and Endo sued by FTC. The healthcare cohort has witnessed several key events in the face of a political backdrop that’s put the entire industry on edge. The overall healthcare umbrella has become sensitive to any tweet from President Trump as he vows to bring down drug prices. As he pursues his crusade against drug pricing, much of these threats may have already been priced-in as seen in many healthcare-related stocks (i.e. McKesson, CVS, ABBV and AGN) that have seen sharp and sustained sell-offs that coincide with the 2017 presidential campaign cycle.
WHAT'S NEXT
Continue reading "Preview Issue #11: J&J $30B Acquisition, Humana/Aetna Blocked and Allergan Sued"